SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-23-296632
Filing Date
2023-12-15
Accepted
2023-12-15 16:06:54
Documents
13
Period of Report
2023-11-07
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d66330d8ka.htm   iXBRL 8-K/A 35458
2 EX-3.2 d66330dex32.htm EX-3.2 108974
  Complete submission text file 0001193125-23-296632.txt   297767

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amrx-20231107.xsd EX-101.SCH 2849
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrx-20231107_lab.xml EX-101.LAB 17944
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrx-20231107_pre.xml EX-101.PRE 11246
7 EXTRACTED XBRL INSTANCE DOCUMENT d66330d8ka_htm.xml XML 3767
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38485 | Film No.: 231490330
SIC: 2834 Pharmaceutical Preparations